Start a conversation

Proposed environment 01

Formulation & Analytical Sciences

Turn formulation choices into traceable development evidence.

Illustrative concept visualActive predevelopmentProposed, not built
View depthCutaway
ExteriorInterior
Illustrative concept visual. No site, building, equipment, operating capability or delivery date is approved or represented as existing.
01
Proposed campus role

Create comparable evidence around formulation and material choices.

02
Decision the concept could support

Which candidate should advance, change, move outside the campus or stop.

03
Potential value

Earlier uncertainty reduction and a clearer future transfer package.

Proposed purpose

Designed around an evidence journey, not a catalogue of rooms.

The proposed building would connect formulation design, material characterisation, analytical procedure development, stability planning and controlled sample knowledge. Its intended role would be to make candidate decisions more informed before later technical and capital commitments were considered.

Illustrative zones

  • Formulation studio
  • Materials characterisation
  • Analytical laboratory
  • Controlled sample archive
  • Shared services

Where value could be created

Formulation quality is decided long before scale.

The proposed environment could help teams compare candidate options earlier, preserve the reasoning behind decisions and identify material, performance and manufacturability questions before greater capital was committed.

  1. 01

    Compare candidates earlier

    Structured formulation screens could make composition, process and delivery choices easier to compare against one scientific question.

    Potential outputA reasoned candidate shortlist
  2. 02

    Understand material risk

    Physical and chemical characterisation could show where solubility, particle behaviour, moisture or solid-state form may affect performance.

    Potential outputCandidate material attributes for further study
  3. 03

    Build transferable methods

    Analytical procedures could be developed around intended purpose, performance criteria and the evidence needed at the applicable stage.

    Potential outputAn analytical development package
  4. 04

    Preserve capital flexibility

    Specialist capability could be added only where repeated programme demand, utilisation and service economics justified internal access.

    Potential outputAn internal access or external service decision
Operating thesis

Capital should follow evidence, repeat demand and accountable delivery. The building would not advance merely because the concept is visually compelling.

Illustrative proposed activities

Inside the science.

How formulation choices could become decision evidence.

These examples describe the level of work that could be evaluated within a future facility. They are not active studies, installed systems or approved methods.

01
Activity

Formulation screening

What happens

Teams could compare excipients, concentration, pH where applicable, mixing conditions and delivery formats against a defined target product profile.

Illustrative system categories

Small volume mixing, controlled dispensing, pH and osmolality measurement, viscosity testing and design of experiments software.

Potential decision output

A shortlist with reasons to advance, reformulate or stop.

Product type, material safety, sample demand and qualified oversight would need to be defined first.
02
Activity

Material characterisation

What happens

Teams could examine particle size, solid-state form, thermal behaviour, moisture response and compatibility where those attributes matter.

Illustrative system categories

Particle analysis, thermal analysis, X ray diffraction, microscopy, spectroscopy and controlled humidity testing.

Potential decision output

A material risk view and attributes to control.

Methods and instruments would be selected only for evidenced programme questions.
03
Activity

Analytical procedure development

What happens

Teams could explore how to measure identity, strength, purity, degradation, release or another defined quality attribute.

Illustrative system categories

Liquid chromatography, mass spectrometry, spectroscopy, dissolution or release testing and reference standards.

Potential decision output

A procedure plan with intended purpose and performance criteria.

Development work would not be described as validated until the applicable evidence and approvals existed.
04
Activity

Stability learning

What happens

Samples could be stored under controlled conditions and reviewed for physical, chemical and performance change over time.

Illustrative system categories

Environmental chambers, controlled sample storage, chromatography, spectroscopy and traceable sample records.

Potential decision output

A stability risk view and questions for formulation, packaging and storage.

Formal stability programmes would require approved protocols, suitable controls and accountable review.

Innovation architecture

A connected formulation knowledge model.

The innovation is not one instrument. It is the proposed connection between material properties, formulation choices, analytical signals, stability observations and accountable decisions.

  1. 01

    Modular scientific workflow

    Spaces and equipment could be configured around proven modality and sample demand rather than a fixed assumption about one product class.

    Potential outputCapability that can expand, contract or remain external
  2. 02

    Traceable sample knowledge

    Samples, conditions, methods, observations and decisions could remain connected through controlled digital records.

    Potential outputA reusable evidence trail
  3. 03

    Transfer designed from the start

    Material and method requirements could be organised for future handoff before scale decisions are made.

    Potential outputA clearer process and analytical transfer brief
InputProduct question

Target profile, materials, risks and intended decision.

Controlled workFormulation and analysis

Designed comparisons with traceable samples and methods.

DecisionCandidate gate

Advance, change, use an external specialist or stop.

HandoffDevelopment package

Candidate rationale, methods, risks and transfer needs.

For the public reader

What this could mean for Scotland.

Potential value for scientific development in Scotland.

In plain English, this building could help turn a promising ingredient into something that can be measured, compared and developed responsibly. Any benefit would begin only if real programmes and a viable operating model existed.

01

Potential route from Scottish ideas to testable products

Researchers and growing companies could explore whether a promising ingredient can become a candidate formulation that can be measured and assessed for further development.

What must be true

Proven demand, safe laboratories, qualified scientists, clear rights and affordable access.

02

Potential routes into laboratory careers

Supervised placements could introduce learners and career changers to formulation, instrumentation and laboratory operations.

What must be true

Formal education partners, trained supervisors, funded places and a safe training plan.

03

Potential opportunity for local suppliers

Future laboratories could require qualified calibration, maintenance, cleaning, waste, consumables and digital support.

What must be true

Transparent procurement, supplier qualification and sustained operating demand.

04

Potential support for stronger investment conversations

Clearer formulation data and reproducible methods could give founders better evidence for development and partner review.

What must be true

Robust data and independent diligence. Evidence would not guarantee investment.

Conditional outcomes

These are potential outcomes, not current impacts. Delivery depends on funded demand, permissions, qualified operators, formal partners, safe operating systems and a credible commercial plan.

From concept to an operating case

Value requires a route to users, the wider campus and proof.

Potential operating routes

01

Sponsored formulation work

Defined programmes for organisations with a clear technical question and contractual scope.

02

Shared analytical access

Selected instrument and method access where utilisation, governance and operator responsibility support it.

03

Transfer packages

Organised formulation and analytical knowledge for qualified future development or manufacturing organisations.

Connected campus

Hands forwardTranslational Development

Characterised candidates, methods and unresolved biological questions.

Hands forwardAdvanced Medicines Manufacturing

Formulation requirements, material risks and initial transfer knowledge.

Hands forwardQuality, Data & Regulatory

Controlled methods, source evidence and candidate decisions.

Evidence required before delivery

This environment advances only when the operating case is stronger than the concept.

  1. 01

    Repeated programme demand and a defined sample flow

  2. 02

    Qualified operators, safety controls and waste routes

  3. 03

    Equipment utilisation and service economics

  4. 04

    Controlled data systems, method ownership and finance

Reference context

These links provide background to selected technical or policy concepts. They do not substantiate delivery, endorse VARUNÉ Labs or prove current capability or regional impact.

ICH quality guidelinesMedicines manufacturing licence guidance